|
|
Sold Out
Book Categories |
| Sect. I | Issues Relevant to the Pre-Transplant Period | 1 |
| Ch. 1 | Aplastic Anemia | 2 |
| Ch. 2 | Acute Myelogenous Leukemia | 14 |
| Ch. 3 | Acute Lymphoblastic Leukemia | 31 |
| Ch. 4 | Chronic Myelogenous Leukemia | 39 |
| Ch. 5 | Myelodysplasia | 49 |
| Ch. 6 | Hodgkin Disease | 63 |
| Ch. 7 | Lymphoma | 76 |
| Ch. 8 | Multiple Myeloma | 83 |
| Ch. 9 | Chronic Lymphocytic Leukemia | 95 |
| Ch. 10 | Breast Cancer | 100 |
| Ch. 11 | Ovarian Cancer | 117 |
| Ch. 12 | Childhood Solid Tumors | 126 |
| Ch. 13 | Germ Cell Tumors | 145 |
| Ch. 14 | Hematopoietic Stem Cell Transplantation for Treatment of Congenital Immunodeficiencies | 154 |
| Ch. 15 | Metabolic Diseases | 169 |
| Ch. 16 | Hemoglobinopathies | 185 |
| Ch. 17 | Gaucher Disease | 193 |
| Ch. 18 | Hematopoietic Stem Cell Transplantation for Severe Autoimmune Disease: Know Thyself | 203 |
| Ch. 19 | In Utero Transplantation | 217 |
| Ch. 20 | Evaluation of Patients Before Hematopoietic Stem Cell Transplantation | 225 |
| Ch. 21 | Histocompatibility | 233 |
| Ch. 22 | Choice of Donor | 253 |
| Ch. 23 | Long-Term Venous Access During Hematopoietic Stem Cell Transplantation | 259 |
| Ch. 24 | Bone Marrow Harvesting | 265 |
| Ch. 25 | Peripheral Blood Progenitor Cell Mobilization and Collection | 269 |
| Ch. 26 | Cord Blood Stem Cells | 287 |
| Ch. 27 | Stem Cell Quantification: The ISHAGE Guidelines for CD34+ Determination - Applications in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation | 298 |
| Ch. 28 | Graft Processing, Storage and Infusion | 312 |
| Ch. 29 | Purging of Contaminating Tumor Cells | 322 |
| Ch. 30 | T-Cell Depletion and Allograft Engineering | 335 |
| Ch. 31 | Immunomodulation After Transplantation | 345 |
| Ch. 32 | Ex Vivo Stem Cell Expansion | 355 |
| Ch. 33 | Hematopoietic Stem Cells as Targets for Gene Therapy | 364 |
| Sect. II | Issues Relevant to the Immediate Transplant Period | 381 |
| Ch. 34 | High-Dose Chemotherapy Conditioning Regimens for Autologous or Allogeneic Hematopoietic Stem Cell Transplantation | 382 |
| Ch. 35 | Choice of Conditioning Regimens | 403 |
| Ch. 36 | Viral Infections | 414 |
| Ch. 37 | Bacteria | 424 |
| Ch. 38 | Fungi and Other Organisms | 435 |
| Ch. 39 | Prevention of Acute Graft-Versus-Host Disease | 452 |
| Ch. 40 | Use of Hematopoietic Growth Factors | 471 |
| Ch. 41 | Coagulopathy During Transplantation | 488 |
| Ch. 42 | Nutritional Issues and Management in Hematopoietic Stem Cell Transplantation | 503 |
| Sect. III | Complications | 509 |
| Ch. 43 | Infection | 510 |
| Ch. 44 | Failure of Engraftment | 521 |
| Ch. 45 | Therapy of Acute Graft-Versus-Host Disease | 531 |
| Ch. 46 | Liver Disease in Hematopoietic Stem Cell Transplant Recipients | 541 |
| Ch. 47 | Mucositis and Other Gastrointestinal Complications | 557 |
| Ch. 48 | Respiratory Complications | 563 |
| Ch. 49 | Neurologic Complications | 578 |
| Ch. 50 | Transfusion Support in Hematopoietic Stem Cell Transplantation | 589 |
| Ch. 51 | Surgical Emergencies | 599 |
| Ch. 52 | Late Graft Failure | 603 |
| Ch. 53 | Infection and Immunization | 608 |
| Ch. 54 | Chronic Graft-Versus-Host Disease | 614 |
| Ch. 55 | Endocrine and Metabolic Complications | 625 |
| Ch. 56 | Relapse After Hematopoietic Stem Cell Transplantation: Mechanisms and Treatment | 637 |
| Ch. 57 | Myelodysplasia and Second Malignancies | 647 |
| Sect. IV | Post-Transplant Therapy | 659 |
| Ch. 58 | Biologic Therapy After Hematopoietic Stem Cell Transplantation | 660 |
| Ch. 59 | Post-Transplant Cytotoxic Therapy | 667 |
| Sect. V | Associated Issues | 671 |
| Ch. 60 | Psychosocial Considerations: A Family Approach to Patient Care | 672 |
| Ch. 61 | Specialized Nursing | 683 |
| Ch. 62 | Coordination and Data Collection | 688 |
| Ch. 63 | Biostatistics | 697 |
| Ch. 64 | Economics | 712 |
| Sect. VI | Regulatory Issues | 721 |
| Ch. 65 | Regulation of Hematopoietic Stem Cell Therapy | 722 |
| Index | 733 |
| Price | Condition | Delivery | Seller | Action |
| $99.99 | Digital |
| WonderClub |
Ian Tyack
reviewed Hematopoietic Stem Cell Therapy on July 08, 2020
Hematopoietic Stem Cell Therapy
I have personal experience with kidney failure.and I'm also a doctor! but I did not choose a specialization yet.The pain which I suffer are increasing day by day.There is no chance for a kidney transplant.This book is very important for me.I understand many things about the history of renal failure. WE Studied at the university some of these things, but from standpoint of therapeutic and functional. I've gained some therapeutic ideas after reading this book,and I plan to transfer to the paper by theory.This is not a book for doctors and medical students only.It is a book for anyone with a personal experience or one of his friends with Renal Failure..
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish List
X
This item is in your Collection
Hematopoietic Stem Cell Therapy
X
This Item is in Your Inventory
Hematopoietic Stem Cell Therapy
X
You must be logged in to review the productsX
X
X
Add Hematopoietic Stem Cell Therapy, This book will be the only current practical guide to a widely used procedure for treating leukemias and disseminated cancers. The contents are organized chronologically, to serve as a step-by-step guide throughout the transplant process. Comprehensive ye, Hematopoietic Stem Cell Therapy to the inventory that you are selling on WonderClubX
X
Add Hematopoietic Stem Cell Therapy, This book will be the only current practical guide to a widely used procedure for treating leukemias and disseminated cancers. The contents are organized chronologically, to serve as a step-by-step guide throughout the transplant process. Comprehensive ye, Hematopoietic Stem Cell Therapy to your collection on WonderClub |